Translational Development Acquisition TDACW Balance Sheet (2023-2026)

NASDAQ TDACW
$1.60 -0.25 (-13.51%)
As of: Sep 9, 2026 · 2:59 PM EDT
Reported Financials

Translational Development Acquisition Quarterly Balance Sheet

Periods 9 quarters
Latest Jun 2026

Translational Development Acquisition reported total assets of $157.37M and total liabilities of $7.79M for the quarter ended Jun 2026, down 11.7% year over year. This balance sheet covers 9 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2023 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.00M0.44M0.21M0.04M0.05M0.03M0.02M0.09M
Cash & Current Investments 0.00M0.44M0.21M0.04M0.05M0.03M0.02M0.09M
Prepaid Assets 0.21M0.21M0.12M0.03M0.01M0.05M0.02M
Current Assets 0.00M0.65M0.42M0.16M0.08M0.04M0.08M0.10M
Non-Current Assets
Long-Term Investments 174.35M176.18M178.03M179.90M181.66M183.27M157.26M
Non-Current Assets 174.35M176.18M178.03M179.90M181.66M183.27M157.26M
Assets 0.00M175.00M176.60M178.18M179.98M181.70M183.35M157.37M
Liabilities
Current Liabilities
Accounts Payables 0.00M0.02M0.23M0.16M0.17M0.16M0.22M0.48M
Notes Payables 0.35M0.10M0.20M0.50M1.10M
Payables 0.35M0.02M0.23M0.16M0.27M0.36M0.72M1.58M
Other Accumulated Expenses 0.00M0.02M0.05M0.08M0.11M0.14M0.17M
Total Current Liabilities 0.51M0.21M0.32M0.28M0.42M0.54M0.86M1.75M
Non-Current Liabilities
Non-Current Deffered Revenue 6.04M6.04M6.04M6.04M6.04M6.04M6.04M
Preferred Stock Liabilities 174.35M176.18M178.03M179.90M181.66M183.27M157.26M
Total Liabilities 0.51M0.57M6.25M6.36M6.32M6.46M6.58M6.90M7.79M
Shareholder's Equity
Total Debt 0.35M0.10M0.20M0.50M1.10M
Common Equity -0.51M-0.57M-5.60M-5.94M-6.17M-6.38M-6.54M-6.82M-7.68M
Liabilities and Shareholders Equity 0.00M175.00M176.60M178.18M179.98M181.70M183.35M157.37M
Retained Earnings -0.53M-5.60M-5.95M-6.17M-6.38M-6.54M-6.82M-7.68M
Treasury Shares 17.25M17.25M17.25M17.25M17.25M17.25M17.25M14.65M